Marvin Barnett

Marvin Barnett serves as a key procurement professional within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate biomedical responses to infectious, immunologic, and allergic threats. He manages a portfolio of scientific and technical service acquisitions, primarily focused on laboratory testing, biocontainment infrastructure, and specialized research support. His work directly enables NIAID’s capacity to develop medical countermeasures and diagnostic tools under high-containment conditions, ensuring rapid readiness for emerging public health threats. Barnett’s acquisitions are strategically aligned with mission-critical research needs, often involving complex, high-safety-level scientific services requiring stringent regulatory and biosafety compliance. His primary contractor relationships center on Quality Biological, Inc., a leading provider of biological reference materials and diagnostic reagents, and Genomic Labs Ltd., a specialist in advanced genomic analysis services. These partnerships reflect a reliance on niche, high-expertise vendors capable of delivering calibrated biological standards, pathogen characterization, and high-throughput sequencing under stringent biosafety protocols. Barnett’s contracting approach emphasizes long-term vendor reliability and technical precision, often resulting in repeat engagements with a small, vetted pool of contractors possessing unique capabilities in biospecimen handling and infectious disease research support. Barnett maintains a balanced approach to socioeconomic set-asides, with equal distribution between full and open competition and total small business set-asides under FAR 19.5. This pattern underscores a deliberate commitment to fostering innovation through small business participation while ensuring access to specialized technical capacity. He consistently prioritizes small business eligibility without compromising on the technical rigor required for high-containment research environments. His procurement focus is concentrated in NAICS 541380 (Testing Laboratories and Services) and 541990 (All Other Professional, Scientific, and Technical Services), reflecting deep engagement with clinical diagnostics, biosafety testing, and specialized scientific consulting. He procures services that support pathogen characterization, reference material certification, and laboratory accreditation—critical functions underpinning NIAID’s public health response infrastructure.